The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Prostanoid Receptors: Structures, Properties, and Functions
Abstract
Prostanoids are the cyclooxygenase metabolites of arachidonic acid and include prostaglandin (PG) D 2, PGE 2, PGF 2α, PGI 2, and thromboxne A 2. They are synthesized and released upon cell stimulation and act on cells in the vicinity of their synthesis to exert their actions. Receptors mediating the actions of prostanoids were recently identified and cloned. They are G protein-coupled receptors with seven transmembrane domains. There are eight types and subtypes of prostanoid receptors that are encoded by different genes but as a whole constitute a subfamily in the superfamily of the rhodopsin-type receptors. Each of the receptors was expressed in cultured cells, and its ligand-binding properties and signal transduction pathways were characterized. Moreover, domains and amino acid residues conferring the specificities of ligand binding and signal transduction are being clarified. Information also is accumulating as to the distribution of these receptors in the body. It is also becoming clear for some types of receptors how expression of their genes is regulated. Furthermore, the gene for each of the eight types of prostanoid receptor has been disrupted, and mice deficient in each type of receptor are being examined to identify and assess the roles played by each receptor under various physiological and pathophysiological conditions. In this article, we summarize these findings and attempt to give an overview of the current status of research on the prostanoid receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Hypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Immunoregulatory Feedback Between Interleukin-1 and Glucocorticoid Hormones
Besedovsky, H., del Rey, A., Sorkin, E., & Dinarello, C. A. (1986) · Science · doi:10.1126/science.3014662 · Cited by 1,519
Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor
Sapolsky, R., Rivier, C., Yamamoto, G., Plotsky, P., & Vale, W. (1987) · Science · doi:10.1126/science.2821621 · Cited by 1,504
THE PHENOMENON OF THE ACUTE PHASE RESPONSE*
Kushner, I. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22124.x · Cited by 1,479
Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient Mice
Lim, H., Paria, B. C., Das, S. K., Dinchuk, J. E., Langenbach, R., Trzaskos, J. M., & Dey, S. K. (1997) · Cell · doi:10.1016/s0092-8674(00)80402-x · Cited by 1,430
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,379
Turning off the signal: desensitization of β‐adrenergic receptor function
Hausdorff, W. P., Caron, M. G., & Lefkowitz, R. J. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.11.2165947 · Cited by 1,249
Fever: Role of Pyrogens and Cryogens
Kluger, M. J. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.1.93 · Cited by 1,215
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Sugimoto, Y., & Narumiya, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600038200 · Cited by 1,196
Self-citationMammalian G Proteins and Their Cell Type Specific Functions
Wettschureck, N., & Offermanns, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2005 · Cited by 1,166
Hirai, H., Tanaka, K., Yoshie, O., Ogawa, K., Kenmotsu, K., Takamori, Y., Ichimasa, M., Sugamura, K., Nakamura, M., Takano, S., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.255 · Cited by 1,099
Selexipag for the Treatment of Pulmonary Arterial Hypertension
Sitbon, O., Channick, R., Chin, K. M., Frey, A., Gaine, S., Galiè, N., Ghofrani, H.-A., Hoeper, M. M., Lang, I. M., Preiss, R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1503184 · Cited by 1,060
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011
Urinary Bladder Contraction and Relaxation: Physiology and Pathophysiology
Andersson, K.-E., & Arner, A. (2004) · Physiological Reviews · doi:10.1152/physrev.00038.2003 · Cited by 949
Hata, A. N., & Breyer, R. M. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.003 · Cited by 840
Drugs, their targets and the nature and number of drug targets
Imming, P., Sinning, C., & Meyer, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2132 · Cited by 839
Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002) · Nature Medicine · doi:10.1038/nm0302-289 · Cited by 836
Bringmann, A., Iandiev, I., Pannicke, T., Wurm, A., Hollborn, M., Wiedemann, P., Osborne, N. N., & Reichenbach, A. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.07.001 · Cited by 761
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
Gastric Mucosal Defense and Cytoprotection: Bench to Bedside
Laine, L., Takeuchi, K., & Tarnawski, A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.05.030 · Cited by 767
Cyclooxygenase-2: A Therapeutic Target
Turini, M. E., & DuBois, R. N. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.103952 · Cited by 683
Central neural pathways for thermoregulation
Morrison, S. (2011) · Frontiers in Bioscience · doi:10.2741/3677 · Cited by 655
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa, J. B., Gilbert, J., & Ochoa, A. C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050715 · Cited by 609
Synopsis of arachidonic acid metabolism: A review
Hanna, V. S., & Hafez, E. A. A. (2018) · Journal of Advanced Research · doi:10.1016/j.jare.2018.03.005 · Cited by 596
Shimizu, T. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145616 · Cited by 576
Genetic and pharmacological analysis of prostanoid receptor function
Narumiya, S., & FitzGerald, G. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13455 · Cited by 568
Self-citationMechanisms underlying the cardioprotective effects of omega-3 polyunsaturated fatty acids
Adkins, Y., & Kelley, D. S. (2010) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2009.12.004 · Cited by 557
Disruption of astrocyte–vascular coupling and the blood–brain barrier by invading glioma cells
Watkins, S., Robel, S., Kimbrough, I. F., Robert, S. M., Ellis-Davies, G., & Sontheimer, H. (2014) · Nature Communications · doi:10.1038/ncomms5196 · Cited by 550
Central circuitries for body temperature regulation and fever
Nakamura, K. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00109.2011 · Cited by 543
Sensitization of TRPV1 by EP1 and IP Reveals Peripheral Nociceptive Mechanism of Prostaglandins
Moriyama, T., Higashi, T., Togashi, K., Iida, T., Segi, E., Sugimoto, Y., Tominaga, T., Narumiya, S., & Tominaga, M. (2005) · Molecular Pain · doi:10.1186/1744-8069-1-3 · Cited by 544
Self-citationPharmacology of Penile Erection
Andersson, K.-E. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01503-5 · Cited by 528
Vascular endothelium – Gatekeeper of vessel health
Cahill, P. A., & Redmond, E. M. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.03.007 · Cited by 518
Platelets at work in primary hemostasis
Broos, K., Feys, H. B., De Meyer, S. F., Vanhoorelbeke, K., & Deckmyn, H. (2011) · Blood Reviews · doi:10.1016/j.blre.2011.03.002 · Cited by 502
Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors
Kawahara, K., Hohjoh, H., Inazumi, T., Tsuchiya, S., & Sugimoto, Y. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.07.008 · Cited by 488
Self-citationRenal Autoregulation in Health and Disease
Carlström, M., Wilcox, C. S., & Arendshorst, W. J. (2015) · Physiological Reviews · doi:10.1152/physrev.00042.2012 · Cited by 485
Andersson, K.-E., & Wein, A. J. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.4.4 · Cited by 484
Koenigsknecht-Talboo, J., & Landreth, G. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1808-05.2005 · Cited by 477
The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Chiang, N., Serhan, C. N., Dahlén, S.-E., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464
Phillis, J. W., Horrocks, L. A., & Farooqui, A. A. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.02.002 · Cited by 459
Woodward, D. F., Jones, R. L., & Narumiya, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003517 · Cited by 443
Self-citationCyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair
Gellersen, B., & Brosens, J. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780357 · Cited by 436
Neuroinflammatory processes in Alzheimer’s disease
Heneka, M. T., O’Banion, M. K., Terwel, D., & Kummer, M. P. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0438-z · Cited by 433
“PGE2 acts on four differ- ent receptors: EP1–EP4 (Narumiya et al. 1999).”
BackgroundCentral control of thermogenesis in mammals
Morrison, S. F., Nakamura, K., & Madden, C. J. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.041848 · Cited by 424
The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214459 · Cited by 418
Self-citationProstaglandins and cycloxygenases in the spinal cord
Vanegas, H., & Schaible, H.-G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00063-0 · Cited by 416
Role of Monocytes in Atherogenesis
ØSTERUD, B., & BJØRKLID, E. (2003) · Physiological Reviews · doi:10.1152/physrev.00005.2003 · Cited by 412
Prostanoids and prostanoid receptors in signal transduction
Bos, C. L., Richel, D. J., Ritsema, T., Peppelenbosch, M. P., & Versteeg, H. H. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2003.08.006 · Cited by 387
Autonomic Nervous System and Immune System Interactions
Kenney, M. J., & Ganta, C. K. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130051 · Cited by 381
Shinmura, K., Tang, X.-L., Wang, Y., Xuan, Y.-T., Liu, S.-Q., Takano, H., Bhatnagar, A., & Bolli, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10197 · Cited by 381
Kobayashi, T., Tahara, Y., Matsumoto, M., Iguchi, M., Sano, H., Murayama, T., Arai, H., Oida, H., Yurugi-Kobayashi, T., Yamashita, J. K., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421446 · Cited by 373
Self-citationAfferent properties and reflex functions of bronchopulmonary C-fibers
Lee, L.-Y., & Pisarri, T. E. (2001) · Respiration Physiology · doi:10.1016/s0034-5687(00)00204-8 · Cited by 372
Adams, I. R., & McLaren, A. (2002) · Development · doi:10.1242/dev.129.5.1155 · Cited by 372
IL‐1β induces COX2, MMP‐1, ‐3 and ‐13, ADAMTS‐4, IL‐1β and IL‐6 in human tendon cells
Tsuzaki, M., Guyton, G., Garrett, W., Archambault, J. M., Herzog, W., Almekinders, L., Bynum, D., Yang, X., & Banes, A. J. (2003) · Journal of Orthopaedic Research · doi:10.1016/s0736-0266(02)00141-9 · Cited by 364
Hishikawa, D., Shindou, H., Kobayashi, S., Nakanishi, H., Taguchi, R., & Shimizu, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712245105 · Cited by 364
15d-PGJ2: The anti-inflammatory prostaglandin?
Scher, J. U., & Pillinger, M. H. (2005) · Clinical Immunology · doi:10.1016/j.clim.2004.09.008 · Cited by 348
Cyclooxygenases, prostanoids, and tumor progression
Wang, M.-T., Honn, K. V., & Nie, D. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9096-5 · Cited by 345
Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation
Yoshida, K., Oida, H., Kobayashi, T., Maruyama, T., Tanaka, M., Katayama, T., Yamaguchi, K., Segi, E., Tsuboyama, T., Matsushita, M., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062053399 · Cited by 345
Self-citationMolecular Pathways: Adipose Inflammation as a Mediator of Obesity-Associated Cancer
Howe, L. R., Subbaramaiah, K., Hudis, C. A., & Dannenberg, A. J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2603 · Cited by 344
(2006) · Operative Pediatric Surgery 6Ed · doi:10.1201/b13237-67 · Cited by 341
GPR109A (PUMA-G/HM74A) mediates nicotinic acid–induced flushing
Benyó, Z., Gille, A., Kero, J., Csiky, M., Suchánková, M. C., Nüsing, R. M., Moers, A., Pfeffer, K., & Offermanns, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23626 · Cited by 340
Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?
Gasparini, G., Longo, R., Sarmiento, R., & Morabito, A. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01220-8 · Cited by 330
Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor
Monneret, G., Gravel, S., Diamond, M., Rokach, J., & Powell, W. S. (2001) · Blood · doi:10.1182/blood.v98.6.1942 · Cited by 326
Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth
Amano, H., Hayashi, I., Endo, H., Kitasato, H., Yamashina, S., Maruyama, T., Kobayashi, M., Satoh, K., Narita, M., Sugimoto, Y., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021408 · Cited by 325
Self-citationFukushima, N., Ishii, I., Contos, J. J., Weiner, J. A., & Chun, J. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.507 · Cited by 322
Kabashima, K., Sakata, D., Nagamachi, M., Miyachi, Y., Inaba, K., & Narumiya, S. (2003) · Nature Medicine · doi:10.1038/nm872 · Cited by 316
Self-citationAhmadi, S., Lippross, S., Neuhuber, W. L., & Zeilhofer, H. U. (2002) · Nature Neuroscience · doi:10.1038/nn778 · Cited by 312
Fujino, H., West, K. A., & Regan, J. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109440200 · Cited by 310
Uematsu, S., Matsumoto, M., Takeda, K., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5811 · Cited by 309
Identification and Characterization of a Novel Type of Membrane-Associated Prostaglandin E Synthase
Tanikawa, N., Ohmiya, Y., Ohkubo, H., Hashimoto, K., Kangawa, K., Kojima, M., Ito, S., & Watanabe, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6531 · Cited by 305
Amaya, F., Wang, H., Costigan, M., Allchorne, A. J., Hatcher, J. P., Egerton, J., Stean, T., Morisset, V., Grose, D., Gunthorpe, M. J., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4015-06.2006 · Cited by 302
The Spinal Phospholipase-Cyclooxygenase-Prostanoid Cascade in Nociceptive Processing
Svensson, C. I., & Yaksh, T. L. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.092401.143905 · Cited by 302
Prostaglandin E2 and Cancer: Insight into Tumor Progression and Immunity
Finetti, F., Travelli, C., Ercoli, J., Colombo, G., Buoso, E., & Trabalzini, L. (2020) · Biology · doi:10.3390/biology9120434 · Cited by 302
Neuroglia in neurodegeneration
Heneka, M. T., Rodríguez, J. J., & Verkhratsky, A. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.11.004 · Cited by 301
Cyclooxygenase-2 Regulates Prostaglandin E2Signaling in Hippocampal Long-Term Synaptic Plasticity
Chen, C., Magee, J. C., & Bazan, N. G. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.87.6.2851 · Cited by 294
Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer
Howe, L. R. (2007) · Breast Cancer Research · doi:10.1186/bcr1678 · Cited by 293
Receptors for prostaglandin E2 that regulate cellular immune responses in the mouse
Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M., Mannon, R. B., Koller, B. H., & Coffman, T. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13640 · Cited by 287
Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis
Sakai, & Tager, A. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.001 · Cited by 285
Yang, G., Im, H.-J., & Wang, J. H.-C. (2005) · Gene · doi:10.1016/j.gene.2005.08.006 · Cited by 282
“Since PGE2 is one of the major lipid mediators of pain and acute inflammation in tendons and other tissues (Narumiya et al., 1999; Fiorucci et al., 2001), we tested for an interactive effect of IL-1β and mechanical stretching on PGE2 production by HPTFs.”
BackgroundReceptors for prostaglandin E2 that regulate cellular immune responses in the mouse
Nataraj, C., Thomas, D. W., Tilley, S. L., Nguyen, M., Mannon, R., Koller, B. H., & Coffman, T. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113640 · Cited by 278
Angeli, V., Faveeuw, C., Roye, O., Fontaine, J., Teissier, E., Capron, A., Wolowczuk, I., Capron, M., & Trottein, F. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.10.1135 · Cited by 274
The Prostanoid EP4 Receptor and Its Signaling Pathway
Yokoyama, U., Iwatsubo, K., Umemura, M., Fujita, T., & Ishikawa, Y. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007195 · Cited by 264
Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases
Tsuge, K., Inazumi, T., Shimamoto, A., & Sugimoto, Y. (2019) · International Immunology · doi:10.1093/intimm/dxz021 · Cited by 263
Self-citationPositive and Negative Regulation of NF-κB by COX-2
Poligone, B., & Baldwin, A. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106599200 · Cited by 263
Bolli, R. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00414-5 · Cited by 258
Hypoxemia, oxygen content, and the regulation of cerebral blood flow
Hoiland, R. L., Bain, A. R., Rieger, M. G., Bailey, D. M., & Ainslie, P. N. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00270.2015 · Cited by 255
Central efferent pathways for cold-defensive and febrile shivering
Nakamura, K., & Morrison, S. F. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.210047 · Cited by 238
The Role of Inflammation in the Pathogenesis of Glaucoma
Vohra, R., Tsai, J. C., & Kolko, M. (2013) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.08.010 · Cited by 214
Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype
Reinold, H., Ahmadi, S., Depner, U. B., Layh, B., Heindl, C., Hamza, M., Pahl, A., Brune, K., Narumiya, S., Müller, U., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23618 · Cited by 202
Self-citationCyclooxygenase-2 in synaptic signaling
Yang, H., & Chen, C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480144 · Cited by 195
Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium
Sales, K. J., & Jabbour, H. N. (2003) · Reproduction · doi:10.1530/rep.0.1260559 · Cited by 177
Prostaglandin E2–EP3 Signaling Induces Inflammatory Swelling by Mast Cell Activation
Morimoto, K., Shirata, N., Taketomi, Y., Tsuchiya, S., Segi-Nishida, E., Inazumi, T., Kabashima, K., Tanaka, S., Murakami, M., Narumiya, S., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300290 · Cited by 132
Self-citationPeritoneal endometriosis is an inflammatory disease
Donnez, J. (2012) · Frontiers in Bioscience · doi:10.2741/e358 · Cited by 127
An airway-to-brain sensory pathway mediates influenza-induced sickness
Bin, N.-R., Prescott, S. L., Horio, N., Wang, Y., Chiu, I. M., & Liberles, S. D. (2023) · Nature · doi:10.1038/s41586-023-05796-0 · Cited by 111
Cyclooxygenase Inhibition as a Strategy to Ameliorate Brain Injury
Hurley, S. D., Olschowka, J. A., & O'Banion, M. K. (2002) · Journal of Neurotrauma · doi:10.1089/089771502753460196 · Cited by 110
Turrin, N. P., & Rivest, S. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422901003 · Cited by 107
Vertebrate Membrane Proteins: Structure, Function, and Insights from Biophysical Approaches
Müller, D. J., Wu, N., & Palczewski, K. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07111 · Cited by 104
Iwasaki, M., Nagata, K., Takano, S., Takahashi, K., Ishii, N., & Ikezawa, Z. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01862.x · Cited by 86
Nasu, K., Nishida, M., Kawano, Y., Tsuno, A., Abe, W., Yuge, A., Takai, N., & Narahara, H. (2011) · Reproductive Sciences · doi:10.1177/1933719110392059 · Cited by 73
Gallant, M. A., Samadfam, R., Hackett, J. A., Antoniou, J., Parent, J.-L., & de Brum-Fernandes, A. J. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041211 · Cited by 70
Hamelin, E., Thériault, C., Laroche, G., & Parent, J.-L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503438200 · Cited by 67
Kopp, U. C., Cicha, M. Z., Nakamura, K., Nüsing, R. M., Smith, L. A., & Hökfelt, T. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00230.2004 · Cited by 61
Lambers, C., Roth, M., Jaksch, P., Muraközy, G., Tamm, M., Klepetko, W., Ghanim, B., & Zhao, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-19294-1 · Cited by 61
FcεRI, but Not FcγR, Signals Induce Prostaglandin D2 and E2 Production from Basophils
Ugajin, T., Satoh, T., Kanamori, T., Aritake, K., Urade, Y., & Yokozeki, H. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.04.023 · Cited by 37
Liu, X., Thangavel, M., Sun, S. Q., Kaminsky, J., Mahautmr, P., Stitham, J., Hwa, J., & Ostrom, R. S. (2008) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-007-0196-0 · Cited by 35
The pro- and anti-tumor roles of mesenchymal stem cells toward BRCA1-IRIS-overexpressing TNBC cells
Ryan, D., Paul, B. T., Koziol, J., & ElShamy, W. M. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1131-2 · Cited by 25
Boeno, C. N., Paloschi, M. V., Lopes, J. A., Souza Silva, M. D., Evangelista, J. R., dos Reis, V. P., da S. Setúbal, S., Soares, A. M., & Zuliani, J. P. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109194 · Cited by 24
Metadata
- Authors
- Narumiya, S., Sugimoto, Y., & Ushikubi, F.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 1999-01-10
- Volume
- 79
- Issue
- 4
- Pages
- 1193-1226
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W2121612337
- Cited by
- 2,412
- References
- 187
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.